Why is it important to risk stratify patients in CLL?
The differences in treating older versus younger CLL patients
The CLL patient: devising a management plan
Developments in prognostic factors of acute myeloid leukemia (AML)
Gert J. Ossenkoppele
Can venetoclax be used to treat multiple myeloma (MM)?